InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Sansone Christopher R., 董事. Officer active across 1 company, notably InfuSystem Holdings, Inc. Cumulatively, 3 reports have been published. Split: 0 buy · 2 sells. Total volume traded: €1.6m. History available since 22 November 2021. The latest transaction was disclosed on 17 November 2022 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Sansone Christopher R.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报3 总计
40,838 股@ US$8.1911.2% 占其流量Common StockSEC:0001628280-22-030596:0
25,000 股@ US$1.982.7% 占其流量Common StockSEC:0001014108-22-000062:0
80,000 股@ US$17.7377.5% 占其流量Common StockSEC:0001014108-21-000201:0
3 条申报中的 3 条
About Sansone Christopher R.
Christopher R. Sansone is a Director at InfuSystem Holdings, Inc. In this role, he contributes to the governance of the company and strategic decision-making. InfuSystem Holdings is a provider of infusion management services. Christopher's experience in the healthcare sector is valuable in guiding the company's direction.
